Crossmark

Intriguing findings of liver fibrosis following COVID-19

Published Online: 2021-10-11

Published Print: 2021-12

Authors

Kolesova, Oksana

Vanaga, Ieva

Laivacuma, Sniedze

Derovs, Aleksejs

Kolesovs, Aleksandrs

Radzina, Maija

Platkajis, Ardis

Eglite, Jelena

Hagina, Elvira

Arutjunana, Seda

Putrins, Davis Simanis

Storozenko, Jelena

Rozentale, Baiba

Viksna, Ludmila
Funding

Funding for this research was provided by:

The Ministry of Education and Science, Republic of Latvia (VPP-COVID-2020/1-0023)
License Information

Text and Data Mining valid from 2021-10-11

Version of Record valid from 2021-10-11
More Information

Article History

Received: 10 May 2021

Accepted: 22 September 2021

First Online: 11 October 2021

Declarations

:

: The Central Medical Ethics Committee, Riga, Latvia (protocol No. 01-29.1/2429), and the Ethics Committee of Rīga Stradiņš University, Latvia (protocol No. 6-1/07/14) provided approval for the study. All participants signed the informed consent form. The study was performed in accordance with the Declaration of Helsinki.

: Not applicable.

: The authors have no conflict of interest to declare.

Document is current